A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838

Trial Profile

A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Bitopertin (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 09 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 15 Jun 2011 Planned end date (1 Nov 2011) added as reported by ClinicalTrials.gov.
    • 15 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top